Effect of <i>ATIC, ADA, ITPA, and AMPD1</i> gene polymorphisms on the efficacy of methotrexate in rheumatoid arthritis-Reference-Cited by-同舟云学术

Effect of <i>ATIC, ADA, ITPA, and AMPD1</i> gene polymorphisms on the efficacy of methotrexate in rheumatoid arthritis

Published:2024-06-16 Issue:1 Volume: Page:4-13
ISSN:2588-0527
Container-title:Pharmacogenetics and Pharmacogenomics
language:
Short-container-title:Fgen_Fgenom

Author:

Devald I. V.¹^ORCID,Khodus E. A.²^ORCID,Myslivtsova K. Yu.²^ORCID,Khromova E. B.³^ORCID,Ignatova G. L.¹^ORCID,Lila A. M.⁴^ORCID,Stashkevich D. S.⁵^ORCID

Affiliation:

1. FSBEI HE "South-Ural State Medical University" MOH Russia

2. Professor Kinzersky Clinic LLC

3. Russian Research Institute of Hematology and Transfusiology

4. FSBSI "V.A. Nasonova Research Institute of Rheumatology"; FSBEI FPE "Russian Medical Academy of Continuous Professional Education" MOH Russia

5. Chelyabinsk State University

Publisher

Publishing House OKI

Reference20 articles.

1. Nasonov EL. Revmatologiya: Klinicheskie rekomendatsii. 2-e izd. GEOTAR Media; 2010. (In Russ.).

2. Smolen JS, Landewé RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020 Jun;79(6):685-699. doi: 10.1136/annrheumdis-2019-216655.

3. Friedman B, Cronstein B. Methotrexate mechanism in treatment of rheumatoid arthritis. Joint Bone Spine. 2019 May;86(3):301-307. doi: 10.1016/j.jbspin.2018.07.004.

4. Rezaei H, Saevarsdottir S, Forslind K, et al. In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial. Ann Rheum Dis. 2012 Feb;71(2):186-91. doi: 10.1136/annrheumdis-2011-200038.

5. Sychev DA. Prikladnaya farmakogenetika: Monografiya. Moscow, Tver': OOO "Izdatel'stvo «Triada»; 2021. (In Russ.).